ADMA Biologics Ownership | Who Owns ADMA Biologics?

Overview Forecast RevenueFinancials Chart Transcripts

ADMA Biologics Ownership Summary

ADMA Biologics is owned by 76.13% institutional investors, 1.87% insiders, and 22.01% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 15.46% of ADMA shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.25% of its assets in ADMA Biologics shares.

ADMA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	ADMA Biologics	76.13%	1.87%	22.01%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Biotech Stocks	35.75%	11.83%	52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	36.83M	15.46%	$331.85M
Vanguard group	20.85M	8.74%	$380.39M
Blackrock	18.64M	8.15%	$208.45M
State street	14.08M	5.91%	$126.90M
Capital research global investors	11.19M	4.70%	$100.83M
Nuveen	6.10M	2.56%	$54.95M
Geode capital management	5.82M	2.44%	$52.48M
Citadel advisors	5.81M	2.44%	$52.35M
Dimensional fund advisors lp	5.01M	2.10%	$45.10M
American century companies	4.79M	2.01%	$43.15M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
B group	3.21M	21.43%	$28.90M
Caligan partners lp	4.76M	2.85%	$42.86M
Stonepine capital management	740.00K	2.67%	$6.67M
Ophir asset management pty	1.26M	2.27%	$18.40M
Oberweis asset management inc/	2.71M	1.52%	$39.76M
Ranger investment management	2.28M	1.49%	$20.58M
First light asset management	1.07M	1.48%	$15.67M
Marathon capital management	627.39K	1.27%	$5.65M
Mesirow institutional investment management	782.45K	1.03%	$13.42M
Clarivest asset management	575.25K	0.66%	$6.43M

Top Buyers

Holder	Shares	% Assets	Change
Capital research global investors	11.19M	0.02%	4.55M
Citadel advisors	5.81M	0.01%	4.29M
Point72 asset management	3.29M	0.04%	2.89M
Millennium management	3.43M	0.01%	2.76M
Jane street group	3.05M	0.00%	2.59M

Top Sellers

Holder	Shares	% Assets	Change
Sachem head capital management lp	-	-	-11.38M
Invesco	4.12M	0.01%	-7.67M
Westfield capital management co lp	-	-	-6.99M
Janus henderson group	98.26K	0.00%	-3.84M
Thrivent financial for lutherans	158.86K	0.00%	-3.63M

New Positions

Holder	Shares	% Assets	Change	Value
Rubric capital management lp	1.81M	0.17%	1.81M	$16.30M
Vanguard fiduciary trust	1.64M	0.00%	1.64M	$14.75M
Jupiter asset management	711.51K	0.03%	711.51K	$6.41M
Clearline capital lp	556.05K	0.26%	556.05K	$5.01M
Ashford capital management	361.50K	0.40%	361.50K	$3.26M

Sold Out

Holder	Change
Mendota financial group	-4.00
Assetmark	-5.00
True wealth design	-11.00
Huntington national bank	-14.00
Global financial private client	-24.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	318	-14.29%	181,408,566	-17.67%	76	0.89%	166	-17.82%	106	-10.92%
Dec 31, 2025	122	-68.06%	37,183,315	-83.04%	15	0.19%	65	-60.37%	34	-78.48%
Sep 30, 2025	154	-58.93%	47,734,498	-76.76%	19	0.27%	60	-74.36%	68	-33.98%
Jun 30, 2025	376	4.16%	204,872,171	0.17%	84	1.15%	230	18.56%	107	-6.96%
Mar 31, 2025	357	8.51%	204,309,752	0.18%	85	1.14%	192	-4.00%	113	9.71%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Core S&P Small-Cap ETF	14.51M	6.25%	3.25K
American Funds SMALLCAP World A	10.28M	4.43%	4.98M
First Trust NYSE Arca Biotech ETF	7.76M	3.34%	-36.16K
Vanguard Total Stock Mkt Idx Inv	7.27M	3.13%	20.78K
Vanguard US Total Market Shares ETF	7.15M	3.01%	281.42K
State Street® SPDR® S&P® Biotech ETF	5.48M	2.36%	-54.23K
iShares Russell 2000 ETF	5.44M	2.34%	45.92K
American Century Small Cap Growth Inv	3.36M	1.45%	200.08K
American Century U.S. Small Cap Growth	3.36M	1.45%	200.08K
SPDR® S&P Biotech ETF	3.25M	1.36%	7.24K

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 27, 2026	Grossman Jerrold B	-	Buy	$50.62K
May 12, 2026	Grossman Jerrold B	-	Buy	$100.13K
May 11, 2026	Grossman Jerrold B	-	Buy	$100.13K
Mar 16, 2026	Grossman Adam S	President and CEO	Sell	$227.40K
Mar 16, 2026	Grossman Adam S	President and CEO	Sell	$90.96K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	3	-
2026 Q1	2	5
2025 Q4	-	6
2025 Q3	-	6
2025 Q2	-	13

ADMA Ownership FAQ

Who Owns ADMA Biologics?

ADMA Biologics shareholders are primarily institutional investors at 76.13%, followed by 1.87% insiders and 22.00% retail investors. The average institutional ownership in ADMA Biologics's industry, Biotech Stocks , is 35.75%, which ADMA Biologics exceeds.

Who owns the most shares of ADMA Biologics?

ADMA Biologics’s largest shareholders are Blackrock funding, inc. /de (36.83M shares, 15.46%), Vanguard group (20.85M shares, 8.74%), and Blackrock (18.64M shares, 8.15%). Together, they hold 32.34% of ADMA Biologics’s total shares outstanding.

Does Blackrock own ADMA Biologics?

Yes, BlackRock owns 8.15% of ADMA Biologics, totaling 18.64M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 208.45M$. In the last quarter, BlackRock increased its holdings by 445.43K shares, a 2.45% change.

Who is ADMA Biologics’s biggest shareholder by percentage of total assets invested?

B group is ADMA Biologics’s biggest shareholder by percentage of total assets invested, with 21.43% of its assets in 3.21M ADMA Biologics shares, valued at 28.9M$.

Who is the top mutual fund holder of ADMA Biologics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of ADMA Biologics shares, with 6.25% of its total shares outstanding invested in 14.51M ADMA Biologics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools